This article first appeared on KevinMD.com. You can read it here. After being prescribed opioids for just one day, individuals can face significant challenges with addiction, with six percent continuing to use opioids a year later, according to the Centers for Disease Control and Prevention (CDC). The likelihood of long-term use increases sharply after five days…
More than 70 healthcare thought leaders, providers, and other innovators gathered in Florida in late January to explore the profound impact that new disruptors are having on healthcare delivery models, financing approaches and outcomes. For the third year in a row, Magellan Health’s ‘Magellan Open Vision Exchange’ (MOVE) innovation forum brought together executives, providers and…
National Eating Disorder Awareness Week is observed annually on the last week of February , to mark the occasion, we are sharing some important Dos and Don’ts for families and friends of people suffering from an eating disorder. Eating disorders can be among the most difficult afflictions for family members and friends to understand. Feelings…
Note: This article originally appeared on LinkedIn, you can read it there by clicking here. You cannot escape the responsibility of tomorrow by evading it today – Abraham Lincoln On one of my many cross-country flights, I started to think about how the concept of employment has changed dramatically over the course of my thirty-year…
Magellan’s Haita Makanji, vice president, clinical specialty solutions, was featured in Managed Healthcare Executive this week, discussing some ground breaking new gene therapies that are available for hemophilia sufferers. These therapies promise the potential of fewer infusions and bleeding episodes. You can read the complete article at Managed Healthcare Executive by clicking here.
As we look back on 2017, it was a year of many milestones on the United States (U.S.) drug approvals front. With 46 novel drugs receiving Food and Drug Administration (FDA) approval, it reached a 21-year high and more than doubled novel drug approvals in 2016. This count does not even include a number of…
Today, much of the conversation around opioid use focuses on ways to more tightly control access, including limits on usage and the mandatory use of databases that can alert physicians to patients’ opioid histories. But for those suffering from Opioid Use Disorder (OUD), combatting addiction is a difficult feat, particularly due to treatment barriers, lack…
As healthcare evolves, reimbursement models continue to shift from volume to value. That means more providers are taking risk and moving into value-based reimbursement models. One such model is the Accountable Care Organization (ACOs) in which the provider has accountability for achieving quality improvements and spending reductions. ACOs are not the only model. In today’s…